EyePoint Pharmaceuticals, Inc. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
EyePoint Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • EyePoint Pharmaceuticals, Inc. Return On Equity for the quarter ending June 30, 2024 was -43.2 %, a 62.4% increase year-over-year.
  • EyePoint Pharmaceuticals, Inc. annual Return On Equity for 2023 was -61.5 %, a 17.2% increase from 2022.
  • EyePoint Pharmaceuticals, Inc. annual Return On Equity for 2022 was -74.2 %, a 58.8% decline from 2021.
  • EyePoint Pharmaceuticals, Inc. annual Return On Equity for 2021 was -46.8 %, a 87.9% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -61.5 +12.8 +17.2% Jan 1, 2023 Dec 31, 2023
2022 -74.2 -27.5 -58.8% Jan 1, 2022 Dec 31, 2022
2021 -46.8 +341 +87.9% Jan 1, 2021 Dec 31, 2021
2020 -388 -74 -23.6% Jan 1, 2020 Dec 31, 2020
2019 -314 +13.4 +4.1% Jan 1, 2019 Dec 31, 2019
2018 -327 -193 -143% Jan 1, 2018 Dec 31, 2018
2017 -135 -27.8 -26% Jul 1, 2016 Jun 30, 2017
2016 -107 -128 -602% Jul 1, 2015 Jun 30, 2016
2015 21.3 +110 Jul 1, 2014 Jun 30, 2015
2014 -88.9 +8.44 +8.67% Jul 1, 2013 Jun 30, 2014
2013 -97.3 +23.5 +19.5% Jul 1, 2012 Jun 30, 2013
2012 -121 Jul 1, 2011 Jun 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.